Keratinizing squamous cell carcinoma develops when squamous epithelial cells undergo malignant transformation while retaining their ability to produce keratin, the tough structural protein normally found in skin, hair, and nails. The causes span a familiar roster of carcinogens, with tobacco, alcohol, ultraviolet radiation, and certain strains of human papillomavirus sitting at the top, though chronic inflammation and immunosuppression also play roles depending on the body site. Prognosis is where the picture gets surprisingly complicated: whether keratinization in a tumor is a good sign or a bad sign depends heavily on where in the body the cancer sits and whether HPV is involved.
What Makes a Squamous Cell Carcinoma “Keratinizing”
Squamous cells line the surfaces of the mouth, throat, lungs, cervix, and skin. When these cells turn cancerous, pathologists classify them partly by how much the tumor still resembles the normal tissue it came from. A keratinizing squamous cell carcinoma produces visible keratin within its cell clusters, often forming concentric whorls called keratin pearls. These pearls are essentially the tumor’s misguided attempt at building what normal squamous cells build: a tough, protective layer. The presence of keratin pearls generally signals that the cancer cells are “well differentiated,” meaning they have not completely lost their original identity. Research on esophageal squamous cell carcinoma has found that keratin pearls serve as an independent predictor of longer overall survival and are associated with lower rates of lymph node spread.1Europe PMC. The prognostic value of keratin pearls in patients with esophageal squamous cell carcinoma
By contrast, nonkeratinizing squamous cell carcinomas produce little or no keratin. They tend to look less like normal tissue under the microscope and are often described as “poorly differentiated.” This distinction is not just academic; it feeds directly into treatment planning and prognosis, as we will see.
Where Keratinizing SCC Most Often Arises
Squamous cell carcinomas can appear almost anywhere that squamous epithelium exists, but certain sites dominate. A study analyzing the morphological and topographical spectrum of squamous cell carcinomas found that the keratinizing subtype was the single most common morphological category, accounting for about 35% of all cases. By anatomical site, the lip, oral cavity, and pharynx together made up the largest share at roughly 57% of cases, followed by female genital organs at about 30%. Skin, digestive organs, and the respiratory system each contributed smaller fractions. Among specific subsites, the uterine cervix stood out, representing the largest single topographical category.2SpringerLink / Europe PMC. Squamous cell carcinoma: morphological & topographical spectrum: a two year analysis
The body site matters because the local environment, the dominant carcinogen, and the role of HPV all shift from one location to another. A keratinizing SCC on the lip has a different cause profile and a different expected outcome than one in the lung or the cervix.
Tobacco, Alcohol, and HPV
For squamous cell carcinomas of the head and neck, tobacco and alcohol remain the primary environmental culprits. In oral squamous cell carcinoma specifically, more than half of patients report a history of smoking, heavy alcohol use, or both. The association is especially stark for the floor of the mouth: patients with SCC at that site were roughly 26 times more likely to have a history of tobacco or alcohol exposure than patients with tumors at other oral sites.3Tobacco Induced Diseases. Oral squamous cell carcinoma: Effect of tobacco and alcohol on cancer location Smoking and drinking do not simply add their risks together; research has shown that each independently raises the odds of oral SCC, and HPV16 seropositivity independently raises the risk further, with an adjusted odds ratio of about 3.3 for HPV16.4PubMed Central. Joint effect of human papillomavirus exposure, smoking and alcohol on risk of oral squamous cell carcinoma
HPV’s relationship with keratinization is important for prognosis. In the oropharynx (the back of the throat, including the tonsils and base of tongue), the nonkeratinizing type has a very strong association with HPV, while the keratinizing type has a weaker association with the virus.5PubMed Central. Morphologic features of conventional squamous cell carcinoma of the oropharynx: ‘keratinizing’ and ‘nonkeratinizing’ histologic types as the basis for a consistent classification system This creates a paradox: in the oropharynx, HPV-positive tumors tend to respond much better to treatment, and those tumors happen to be nonkeratinizing. So the keratinizing label in the oropharynx often signals a tobacco-driven, HPV-negative cancer with a worse outlook. The biology driving the cancer matters more than the keratin itself.
UV Radiation, Chronic Inflammation, and Precancerous Lesions
For cutaneous (skin) squamous cell carcinoma, ultraviolet radiation is the dominant cause. UV exposure damages DNA in epidermal keratinocytes either directly or through the generation of reactive oxygen species. Normally, damaged cells are eliminated through built-in safeguard mechanisms, including programmed cell death. When those safeguards fail, premalignant cells survive and accumulate further mutations.6PubMed Central. UV-induced squamous cell carcinoma–a role for antiapoptotic signalling pathways Cutaneous SCC is the second most common non-melanoma skin cancer, and the vast majority of cases arise from actinic keratoses, the rough, scaly patches that develop on chronically sun-exposed skin.7Frontiers in Immunology. From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments
Chronic inflammation is another pathway, particularly in sites not exposed to UV. A case from Uganda illustrated how long-standing inflammation of the foreskin (chronic balanoposthitis), compounded by diabetes and poor foreskin ventilation, created a sustained inflammatory microenvironment that predisposed to keratinizing penile SCC.8PubMed Central. Keratinizing Penile Squamous Cell Carcinoma Arising from Chronic Balanoposthitis in an Uncircumcised Diabetic Man: A Case Report from a Rural Tertiary Hospital in Uganda The general principle applies broadly: chronic irritation of squamous epithelium, whether from infection, scarring, or ongoing tissue damage, can push cells toward malignant transformation over time. Burn scars, chronic wounds, and conditions that cause persistent mucosal irritation are all recognized contributors at various body sites.
Key Molecular Drivers
Regardless of the external trigger, the molecular events inside the cell follow some common themes. One of the earliest and most critical events in cutaneous SCC development is mutation of the TP53 gene. TP53 normally acts as a tumor suppressor, halting the growth of damaged cells or directing them to self-destruct. When TP53 is knocked out, cells with DNA damage survive and accumulate additional cancer-promoting mutations.9Europe PMC / Cancers. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma TP53 mutations are found at high rates across squamous cell carcinomas of the skin, head and neck, lung, and esophagus, making it one of the most universal molecular features of these cancers.
Another major player is the epidermal growth factor receptor (EGFR), a protein that sits on the cell surface and, when activated, tells the cell to grow and divide. EGFR is overexpressed in most oral squamous cell carcinomas; one study found positive EGFR staining in nearly 88% of cases, and higher EGFR expression correlated with greater lymphatic vessel density, suggesting a link to the cancer’s ability to spread through lymphatic channels.10PubMed Central. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis In cutaneous SCC as well, EGFR levels are elevated in tumor tissue compared to normal skin, and experimental work has shown that blocking EGFR signaling can suppress SCC cell growth.11PubMed. Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma
Prognosis Varies Dramatically by Body Site
This is the part of the story that surprises many people. You might assume that a well-differentiated, keratinizing tumor would always carry a better prognosis than a poorly differentiated, nonkeratinizing one. In some locations, that assumption holds. In others, it is exactly backward.
In the oral cavity (tongue, gums, floor of mouth), higher keratinization is indeed a favorable sign. One study found that patients with well-keratinized oral SCC had a five-year disease-free survival of about 93%, compared to roughly 53% for those with low keratinization. Keratinization turned out to be an independent prognostic factor for recurrence, alongside extracapsular spread of lymph node disease.12PubMed. Degree of Keratinization Is an Independent Prognostic Factor in Oral Squamous Cell Carcinoma
In the oropharynx (tonsils, base of tongue), the relationship flips. Patients with nonkeratinizing oropharyngeal SCC had a five-year disease-specific survival of about 63%, versus roughly 45% for those with keratinizing tumors.13JAMA Otolaryngology–Head & Neck Surgery. Association of Keratinization With 5-Year Disease-Specific Survival in Oropharyngeal Squamous Cell Carcinoma The reason, as noted earlier, is largely HPV: nonkeratinizing oropharyngeal tumors are overwhelmingly HPV-driven, and HPV-positive cancers respond far better to chemoradiation.
In the uterine cervix, keratinizing SCC carries a modestly worse overall survival than its nonkeratinizing counterpart, with five-year survival rates of about 63% versus 65%. The gap widens for patients treated with radiation alone: median survival was 33 months for keratinizing tumors versus 38 months for nonkeratinizing ones. Without any treatment, the difference was especially stark, with median survival of 10 months for keratinizing cervical SCC compared to 28 months for nonkeratinizing.14PubMed. Prognostic significance of keratinization in squamous cell cancer of uterine cervix: a population based study Researchers have suggested that keratinizing cervical SCC may be inherently less sensitive to radiation, which partly explains the survival difference.
In the lung, the pattern echoes what is seen in the cervix. Five-year relative survival for keratinizing squamous cell lung cancer was about 21%, compared to roughly 29% for the nonkeratinizing type. The survival disadvantage for keratinizing tumors held across both younger and older age groups.15Journal of Thoracic Oncology. Impact of Keratinization on Survival in Pulmonary Squamous Cell Carcinoma
What Drives Metastasis Risk
Prognosis is not shaped by keratinization alone. Whether a squamous cell carcinoma spreads to lymph nodes depends on a combination of tumor characteristics. In cutaneous SCC, a long-term retrospective study identified tumor diameter greater than 2 cm, tumor thickness beyond 6 mm, and invasion past the subcutaneous fat layer as independent risk factors for lymph node metastasis, with each roughly tripling the hazard.16PubMed. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients Poor differentiation was also linked to lymph node spread in the initial analysis, reinforcing the general pattern that less-differentiated tumors tend to be more aggressive.
In the oral cavity, a systematic review and meta-analysis found that lymphovascular invasion, the presence of cancer cells within blood vessels or lymphatic channels, was a strong predictor of lymph node metastasis.17PubMed Central. Histopathological predictors of lymph node metastasis in oral cavity squamous cell carcinoma: a systematic review and meta-analysis These pathological features appear in the biopsy report alongside keratinization status and collectively shape the staging and treatment decisions that follow.
How Keratinization Affects Treatment Choices
The observation that keratinizing tumors at some sites are less radiosensitive has prompted research into ways to overcome that resistance. A recent study on HPV-negative head and neck SCC developed a keratinization-related gene signature and found that tumors with low expression of these keratinization genes had worse survival and reduced sensitivity to radiation. Experimentally, activating keratinization pathways using all-trans retinoic acid (ATRA) actually sensitized the cancer cells to radiation therapy, both in cell cultures and in animal models.18PubMed Central. Keratinization-related gene signature predicting survival and response to radiation in patients with HPV-negative head and neck squamous cell carcinoma via regulation of cornification and integrin signaling If this approach holds up in clinical trials, it could open a new way to improve radiation outcomes in difficult-to-treat keratinizing and HPV-negative tumors.
Immunotherapy, particularly drugs that block the PD-1/PD-L1 checkpoint, has become an important treatment option in advanced squamous cell carcinomas. But keratinization status influences how likely a tumor is to respond. In non-small cell lung cancer, a small study found that the majority of SCC cases with high PD-L1 expression (the marker most commonly used to predict immunotherapy benefit) were poorly differentiated or nonkeratinizing. Among highly PD-L1-positive cases, about two-thirds were nonkeratinizing, while only a third were keratinizing.19International Journal of Cancer and Clinical Research. Correlation of PD-L1 Expression with Histological Patterns and Treatment Response in Non-Small Cell Lung Cancer This does not mean keratinizing tumors never respond to immunotherapy, but it does suggest they may be less likely to carry the biomarkers currently used to select patients for these drugs.
In cutaneous SCC, spatial analysis of the tumor at single-cell resolution has revealed that the specific arrangement of immune cells and tumor cells within the tissue predicts response to PD-1/PD-L1 blockade better than PD-L1 staining alone.20Journal for ImmunoTherapy of Cancer. Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma The tumor microenvironment, not just the cancer cells themselves, plays a decisive role in whether immunotherapy works.
The Tumor Microenvironment and Stromal Barriers
Speaking of the microenvironment, keratinizing SCCs often develop a dense stromal reaction around the tumor. This process, called desmoplasia, involves cancer-associated fibroblasts remodeling the tissue surrounding the tumor into a thick, collagen-rich barrier. This stromal reaction does not just sit passively around the cancer; it actively promotes invasion and helps the tumor resist treatment. Research has shown that desmoplasia promotes the transition of epithelial cancer cells into a more mobile, invasive state, and can interfere with both chemotherapy and immune checkpoint inhibitors.21PubMed Central. Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier
In oral SCC, this desmoplastic reaction appears to start with infiltration of inflammatory cells into the stroma, followed by dense collagen deposition. Dense plasma cell infiltrates have been identified as early players in this process.22PubMed Central. Dense Plasma Cell Infiltrates Foster Stromal Desmoplasia and Immune Evasion in Oral Squamous Cell Carcinoma The implication is that the tissue surrounding the tumor is not simply a bystander. It actively shapes how the cancer grows, how it spreads, and how it evades the immune system. Targeting this stromal compartment alongside the tumor itself is an active area of therapeutic research, though clinical applications remain early.
Salivary Biomarkers for Earlier Detection
Catching squamous cell carcinoma earlier is one of the most effective ways to improve outcomes, regardless of keratinization status. For cancers of the head and neck and oral cavity, saliva-based testing is emerging as a non-invasive screening tool. A systematic review and network meta-analysis evaluated multiple salivary biomarkers for their ability to detect oral and head/neck SCCs. For oral SCC, two markers showed the highest sensitivity at about 94%, with balanced accuracy above 90%. For head and neck SCC more broadly, markers including actin and certain interleukin proteins performed well, with sensitivity above 90% and reasonable specificity.23Europe PMC. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis These tests are still being validated for routine clinical use, but the idea that a saliva sample could flag an oral or throat cancer before it becomes symptomatic is a meaningful step toward earlier diagnosis, when the prognosis for both keratinizing and nonkeratinizing subtypes is substantially better.
On the skin side, the precancerous pathway is more straightforward to monitor. Since the large majority of cutaneous SCCs arise from actinic keratoses, regular skin checks and treatment of these precursor lesions remain the most direct prevention strategy. Dermatologists treat actinic keratoses with cryotherapy, topical medications, and photodynamic therapy, among other approaches, aiming to eliminate the precancerous cells before they gain the additional mutations needed for full malignant transformation. For people with significant cumulative sun exposure, organ transplant recipients, or anyone on long-term immunosuppressive therapy, this surveillance is especially important, because these groups carry a dramatically elevated risk of cutaneous SCC.